Peter Salzmann, the Chief Executive Officer of $IMVT, sold 28,094 shares of the company on 04-09-2025 for an estimated $364,941. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.3% of their shares of this class of stock. Following this trade, they now own 1,186,512 shares of this class of $IMVT stock.
$IMVT Insider Trading Activity
$IMVT insiders have traded $IMVT stock on the open market 30 times in the past 6 months. Of those trades, 1 have been purchases and 29 have been sales.
Here’s a breakdown of recent trading of $IMVT stock by insiders over the last 6 months:
- SCIENCES LTD. ROIVANT purchased 16,845,010 shares for an estimated $336,900,200
- PETER SALZMANN (Chief Executive Officer) has made 0 purchases and 6 sales selling 67,753 shares for an estimated $1,383,527.
- EVA RENEE BARNETT (Chief Financial Officer) has made 0 purchases and 5 sales selling 13,848 shares for an estimated $354,087.
- MARK S. LEVINE (Chief Legal Officer) has made 0 purchases and 3 sales selling 10,871 shares for an estimated $304,012.
- WILLIAM L. MACIAS (Chief Medical Officer) has made 0 purchases and 7 sales selling 8,924 shares for an estimated $233,898.
- ATUL PANDE sold 7,750 shares for an estimated $221,185
- MICHAEL GEFFNER (Chief Medical Officer) has made 0 purchases and 2 sales selling 5,846 shares for an estimated $156,849.
- ANDREW J. FROMKIN has made 0 purchases and 2 sales selling 8,000 shares for an estimated $156,768.
- DOUGLAS J. HUGHES sold 5,425 shares for an estimated $154,829
- JAY S STOUT (Chief Technology Officer) has made 0 purchases and 2 sales selling 4,935 shares for an estimated $132,692.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IMVT Hedge Fund Activity
We have seen 93 institutional investors add shares of $IMVT stock to their portfolio, and 89 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,786,217 shares (+53.6%) to their portfolio in Q4 2024, for an estimated $44,244,595
- DEEP TRACK CAPITAL, LP added 1,652,536 shares (+38.0%) to their portfolio in Q4 2024, for an estimated $40,933,316
- PARADIGM BIOCAPITAL ADVISORS LP removed 1,362,827 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $33,757,224
- CAPITAL RESEARCH GLOBAL INVESTORS removed 976,237 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $24,181,390
- JPMORGAN CHASE & CO added 925,081 shares (+405.3%) to their portfolio in Q4 2024, for an estimated $22,914,256
- VIKING GLOBAL INVESTORS LP removed 913,612 shares (-39.4%) from their portfolio in Q4 2024, for an estimated $22,630,169
- TWO SEAS CAPITAL LP added 835,000 shares (+123.4%) to their portfolio in Q4 2024, for an estimated $20,682,950
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$IMVT Analyst Ratings
Wall Street analysts have issued reports on $IMVT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 12/19/2024
To track analyst ratings and price targets for $IMVT, check out Quiver Quantitative's $IMVT forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
